IL132758A0 - Methods for treating inflammation and inflammatory diseases using padprt - Google Patents
Methods for treating inflammation and inflammatory diseases using padprtInfo
- Publication number
- IL132758A0 IL132758A0 IL13275898A IL13275898A IL132758A0 IL 132758 A0 IL132758 A0 IL 132758A0 IL 13275898 A IL13275898 A IL 13275898A IL 13275898 A IL13275898 A IL 13275898A IL 132758 A0 IL132758 A0 IL 132758A0
- Authority
- IL
- Israel
- Prior art keywords
- padprt
- methods
- inflammatory diseases
- treating inflammation
- inflammation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/855,616 US5908861A (en) | 1997-05-13 | 1997-05-13 | Methods for treating inflammation and inflammatory disease using pADPRT inhibitors |
US09/056,396 US6303629B1 (en) | 1997-05-13 | 1998-04-06 | Methods for treating inflammation, inflammatory diseases, arthritis and stroke using pADPRT inhibitors |
PCT/US1998/010033 WO1998051308A1 (en) | 1997-05-13 | 1998-05-13 | METHODS FOR TREATING INFLAMMATION AND INFLAMMATORY DISEASES USING pADPRT INHIBITORS |
Publications (1)
Publication Number | Publication Date |
---|---|
IL132758A0 true IL132758A0 (en) | 2001-03-19 |
Family
ID=26735288
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13275898A IL132758A0 (en) | 1997-05-13 | 1998-05-13 | Methods for treating inflammation and inflammatory diseases using padprt |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1009404A4 (en) |
JP (1) | JP4362638B2 (en) |
CN (1) | CN1198614C (en) |
AU (2) | AU745790B2 (en) |
BR (1) | BR9809115A (en) |
CA (1) | CA2289119C (en) |
IL (1) | IL132758A0 (en) |
NZ (1) | NZ501650A (en) |
WO (2) | WO1998051307A1 (en) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI20691B (en) | 1999-01-11 | 2008-10-31 | Agouron Pharma | Tricyclic inhibitors of poly(adp-ribose) polymerases |
ECSP003637A (en) | 1999-08-31 | 2002-03-25 | Agouron Pharma | TRICYCLE POLY INHIBITORS (ADP-RIBOSA) POLYMERASES |
DE60218458T2 (en) | 2001-05-08 | 2007-11-15 | Kudos Pharmaceuticals Ltd. | ISOCHINOLINONE DERIVATIVES AS PARP INHIBITORS |
US7196085B2 (en) | 2002-04-30 | 2007-03-27 | Kudos Pharmaceuticals Limited | Phthalazinone derivatives |
GB0305681D0 (en) | 2003-03-12 | 2003-04-16 | Kudos Pharm Ltd | Phthalazinone derivatives |
US7449464B2 (en) | 2003-03-12 | 2008-11-11 | Kudos Pharmaceuticals Limited | Phthalazinone derivatives |
TW200536830A (en) | 2004-02-06 | 2005-11-16 | Chugai Pharmaceutical Co Ltd | 1-(2H)-isoquinolone derivative |
TWI389897B (en) | 2005-02-22 | 2013-03-21 | Chugai Pharmaceutical Co Ltd | 1- (2H) -isoquinolinone derivatives |
KR20080031266A (en) * | 2005-06-10 | 2008-04-08 | 바이파 사이언스 인코포레이티드 | Parp modulators and treatment of cancer |
GB0521373D0 (en) | 2005-10-20 | 2005-11-30 | Kudos Pharm Ltd | Pthalazinone derivatives |
US7994222B2 (en) * | 2006-09-05 | 2011-08-09 | Bipar Sciences, Inc. | Monitoring of the inhibition of fatty acid synthesis by iodo-nitrobenzamide compounds |
EP2059802A4 (en) * | 2006-09-05 | 2010-09-08 | Bipar Sciences Inc | Methods for designing parp inhibitors and uses thereof |
WO2008091555A2 (en) | 2007-01-22 | 2008-07-31 | Gtx, Inc. | Nuclear receptor binding agents |
US9623021B2 (en) | 2007-01-22 | 2017-04-18 | Gtx, Inc. | Nuclear receptor binding agents |
US9604931B2 (en) | 2007-01-22 | 2017-03-28 | Gtx, Inc. | Nuclear receptor binding agents |
CN101641339B (en) | 2007-02-01 | 2013-07-17 | 雷斯韦洛吉克斯公司 | Compounds for the prevention and treatment of cardiovascular diseases |
AU2008299721A1 (en) | 2007-09-14 | 2009-03-19 | Astrazeneca Ab | Phthalazinone derivatives |
UY31603A1 (en) | 2008-01-23 | 2009-08-31 | DERIVATIVES OF FTALAZINONA | |
KR101629356B1 (en) | 2008-06-26 | 2016-06-13 | 리스버로직스 코퍼레이션 | Methods of preparing quinazolinone derivatives |
HUE030800T2 (en) | 2008-10-07 | 2017-05-29 | Astrazeneca Uk Ltd | Pharmaceutical formulation 514 |
EP2377871A4 (en) | 2008-11-28 | 2012-07-25 | Chugai Pharmaceutical Co Ltd | 1-(2h)-isoquinolone derivative |
AU2010204106B2 (en) | 2009-01-08 | 2014-05-08 | Resverlogix Corp. | Compounds for the prevention and treatment of cardiovascular disease |
MX2021012876A (en) | 2009-03-18 | 2022-06-23 | Resverlogix Corp | Novel anti-inflammatory agents. |
ES2821018T3 (en) | 2009-04-22 | 2021-04-23 | Resverlogix Corp | New anti-inflammatory agents |
PT2773354T (en) | 2011-11-01 | 2019-07-17 | Resverlogix Corp | Oral immediate release formulations for substituted quinazolinones |
WO2014080291A2 (en) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Biaryl derivatives as bromodomain inhibitors |
US9073878B2 (en) | 2012-11-21 | 2015-07-07 | Zenith Epigenetics Corp. | Cyclic amines as bromodomain inhibitors |
AU2013365926B9 (en) | 2012-12-21 | 2019-01-17 | Zenith Epigenetics Ltd. | Novel heterocyclic compounds as bromodomain inhibitors |
US10111885B2 (en) | 2015-03-13 | 2018-10-30 | Resverlogix Corp. | Compositions and therapeutic methods for the treatment of complement-associated diseases |
WO2018237327A1 (en) | 2017-06-22 | 2018-12-27 | Triact Therapeutics, Inc. | Methods of treating glioblastoma |
WO2019067991A1 (en) | 2017-09-29 | 2019-04-04 | Triact Therapeutics, Inc. | Iniparib formulations and uses thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05503073A (en) | 1989-09-26 | 1993-05-27 | オクタマー,インコーポレイテッド | 6-Amino-1,2-benzopyrone useful in the treatment of viral diseases |
US5484951A (en) * | 1990-10-19 | 1996-01-16 | Octamer, Incorporated | 5-iodo-6-amino-6-nitroso-1,2-benzopyrones useful as cytostatic and antiviral agents |
US5482975A (en) | 1991-10-22 | 1996-01-09 | Octamer, Inc. | Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as retroviral inactivating agents, anti-retroviral agents and anti-tumor agents |
US5473074A (en) | 1991-10-22 | 1995-12-05 | Octamer, Incorporated | Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as retroviral inactivating agents, anti-retroviral agents and anti-tumor agents-54 |
US5516941A (en) | 1991-10-22 | 1996-05-14 | Octamer, Inc. | Specific inactivators of "retroviral" (asymmetric) zinc fingers |
US5464871A (en) | 1993-05-12 | 1995-11-07 | Octamer, Inc. | Aromatic nitro and nitroso compounds and their metabolites useful as anti-viral and anti-tumor agents |
DE4436127A1 (en) | 1994-09-27 | 1996-03-28 | Deutsches Rheumaforschungszent | Use of benzoic or pyridine:carboxylic acid or amide cpds. |
AU5259296A (en) * | 1995-04-07 | 1996-10-23 | Warner-Lambert Company | Flavones and coumarins as agents for the treatment of athero sclerosis |
US10766598B2 (en) | 2017-06-14 | 2020-09-08 | The Boeing Company | Wing-to-fuselage joints and aircraft including the same |
-
1998
- 1998-05-13 BR BR9809115-8A patent/BR9809115A/en not_active Application Discontinuation
- 1998-05-13 AU AU74926/98A patent/AU745790B2/en not_active Ceased
- 1998-05-13 CN CNB988063891A patent/CN1198614C/en not_active Expired - Fee Related
- 1998-05-13 IL IL13275898A patent/IL132758A0/en unknown
- 1998-05-13 NZ NZ501650A patent/NZ501650A/en not_active IP Right Cessation
- 1998-05-13 AU AU74847/98A patent/AU7484798A/en not_active Abandoned
- 1998-05-13 WO PCT/US1998/009768 patent/WO1998051307A1/en active Application Filing
- 1998-05-13 CA CA2289119A patent/CA2289119C/en not_active Expired - Fee Related
- 1998-05-13 EP EP98922359A patent/EP1009404A4/en not_active Ceased
- 1998-05-13 WO PCT/US1998/010033 patent/WO1998051308A1/en not_active Application Discontinuation
- 1998-05-13 JP JP54960898A patent/JP4362638B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2289119A1 (en) | 1998-11-19 |
WO1998051308A1 (en) | 1998-11-19 |
JP4362638B2 (en) | 2009-11-11 |
JP2002502367A (en) | 2002-01-22 |
AU745790B2 (en) | 2002-03-28 |
BR9809115A (en) | 2002-01-02 |
EP1009404A1 (en) | 2000-06-21 |
CN1261278A (en) | 2000-07-26 |
AU7484798A (en) | 1998-12-08 |
CN1198614C (en) | 2005-04-27 |
WO1998051307A1 (en) | 1998-11-19 |
NZ501650A (en) | 2001-11-30 |
EP1009404A4 (en) | 2009-07-01 |
AU7492698A (en) | 1998-12-08 |
CA2289119C (en) | 2011-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL132758A0 (en) | Methods for treating inflammation and inflammatory diseases using padprt | |
GR3036364T3 (en) | Compositions and methods for treating or preventing inflammatory diseases | |
HUP0004170A3 (en) | Methods and materials for treating and preventing inflammation ofmucosal tissue | |
HU9603041D0 (en) | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases | |
IL132318A0 (en) | Substituted imidazoles useful in the treatment of inflammatory diseases | |
GB9711208D0 (en) | Therapeutic structure and method | |
IL138871A0 (en) | Flushable diaper and method | |
IL132145A0 (en) | Methods and compositions for treating inflammatory bowel disease | |
AU7132998A (en) | Substituted pyrrolopyridines useful in the treatment of inflammatory diseases | |
PL348059A1 (en) | Compounds useful in the treatment of inflammatory diseases | |
EP0861092A4 (en) | Therapy for cellular accumulation in chronic inflammatory diseases | |
HRP950499B1 (en) | Compositions and methods for treating mast-cell inflammatory condition | |
EP0954303A4 (en) | Methods of treating mental diseases, inflammation and pain | |
IL126759A0 (en) | Method for treating inflammation | |
PL314996A1 (en) | Kappa-opiatagonistic agents for treating intestinal inflammatory diseases | |
IL130485A0 (en) | New treatment for joint inflammation | |
ZA95701B (en) | Rivets-nails and methods for their implementation | |
GB9719161D0 (en) | New therapeutic method | |
AU4515001A (en) | Compositions and methods for locally treating inflammatory diseases | |
HK1044468A1 (en) | Small peptides and methods for treatment of asthma and inflammation | |
IL138654A0 (en) | Methods and materials for treating inflammatory diseases | |
AU8049098A (en) | Composition and methods for the treatment of inflammatory diseases | |
EP1112250A4 (en) | Therapeutic compounds and methods | |
GB9617346D0 (en) | Therapeutic methods and compositions for use therein | |
ZA979453B (en) | Oncostatin M for treating inflammation |